These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Sample size considerations for establishing clinical bioequivalence of allergen formulations. Rabin RL; Slater JE; Lachenbruch P; Pastor RW Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):24-33. PubMed ID: 15119019 [TBL] [Abstract][Full Text] [Related]
7. [The absence of statistical significance in a clinical trial does not mean therapeutic equivalence]. Argimon JM Med Clin (Barc); 2002 May; 118(18):701-3. PubMed ID: 12042136 [No Abstract] [Full Text] [Related]
8. Report of workshop aimed at defining guidelines for caries clinical trials: superiority and equivalency claims for anticaries dentifrices. Council on Dental Therapeutics. J Am Dent Assoc; 1988 Oct; 117(5):663-5. PubMed ID: 3225378 [No Abstract] [Full Text] [Related]
9. Stent-versus-stent equivalency trials : are some stents more equal than others? Edelman ER; Rogers C Circulation; 1999 Aug; 100(9):896-8. PubMed ID: 10468517 [No Abstract] [Full Text] [Related]
10. Comparable therapeutic efficacy of tryptophan and imipramine: average therapeutic ratings versus "true" equivalence. An important difference. Kline NS; Shah BK Curr Ther Res Clin Exp; 1973 Jul; 15(7):484-7. PubMed ID: 4198311 [No Abstract] [Full Text] [Related]
11. [Does LMV consider comparative clinical trials between generic and original preparations unnecessary?]. Bergmark T Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3567. PubMed ID: 19133589 [No Abstract] [Full Text] [Related]
12. Equivalency of two lots of heparin and their effects on various coagulation tests. Heinrich RA; Smith TC; Moyer CE Curr Ther Res Clin Exp; 1976 Nov; 20(5):725-34. PubMed ID: 825358 [No Abstract] [Full Text] [Related]
14. Noninferiority and equivalence trials: deciphering 'similarity' of medical interventions. Powers JH Stat Med; 2008 Feb; 27(3):343-52. PubMed ID: 18186148 [No Abstract] [Full Text] [Related]
15. [Clinical trial of drugs (10): evaluation of drugs]. Sjöqvist F Lakartidningen; 1970 Jun; 67():Suppl II:111+. PubMed ID: 4920747 [No Abstract] [Full Text] [Related]
16. [Assessment and positioning of drugs as equivalent therapeutic alternatives]. Alegre Del Rey EJ; Fénix Caballero S; Castaño Lara R; Sierra García F Med Clin (Barc); 2014 Jul; 143(2):85-90. PubMed ID: 24480291 [No Abstract] [Full Text] [Related]
17. The conditional binomial test revisited for clinical trials. Lei X; Davis D; Kuan L; Lee J; Oh S J Biopharm Stat; 1998 Nov; 8(4):533-43. PubMed ID: 9855032 [TBL] [Abstract][Full Text] [Related]
18. Scientific and ethical issues in equivalence trials. Djulbegovic B; Clarke M JAMA; 2001 Mar; 285(9):1206-8. PubMed ID: 11231752 [No Abstract] [Full Text] [Related]
19. [Equivalence and non-inferiority trials]. Lange S; Bender R; Ziegler A Dtsch Med Wochenschr; 2007; 132 Suppl 1():e53-6. PubMed ID: 17530600 [No Abstract] [Full Text] [Related]
20. Comments on 'Estimation in AB/BA crossover trials with application to bioequivalence studies with incomplete and complete data designs'. Yan Z Stat Med; 2013 Dec; 32(30):5484-6. PubMed ID: 24302283 [No Abstract] [Full Text] [Related] [Next] [New Search]